Phillip Dumesic, MD, PhD

Phillip Dumesic received his BS in Biological Sciences from Stanford, where he worked with Paul Khavari on how MAP kinase signaling drives skin cancer. He then completed his MD-PhD in the UCSF Medical Scientist Training Program. Phillip’s graduate work with Hiten Madhani addressed how specificity is achieved by gene silencing pathways such as RNA interference, repressive chromatin, and DNA methylation, the latter work supported also by a stint in the laboratory of Geeta Narlikar. Phillip next worked as a postdoctoral fellow with Bruce Spiegelman at the Dana-Farber Cancer Institute and Harvard Medical School. There, he studied how regulated mRNA translation contributes to specialized programs of cellular energy metabolism. Phillip returned to UCSF at the Diabetes Center in 2024 as an Assistant Professor in the Department of Medicine. His research has been supported by the Damon Runyon Cancer Research Foundation and the National Institutes of Health